Bayer Looks For Capital As Monsanto Litigation Continues
Amid ongoing legal troubles with its subsidiary Monsanto, Bayer AG is seeking shareholder approval to raise equity capital worth 35% of its current share capital as it works to contain U.S....To view the full article, register now.
Already a subscriber? Click here to view full article